Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Petmed Express Inc (PETS)

Petmed Express Inc (PETS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,198
  • Shares Outstanding, K 21,016
  • Annual Sales, $ 226,970 K
  • Annual Income, $ -6,270 K
  • EBIT $ 7 M
  • EBITDA $ 14 M
  • 60-Month Beta 0.75
  • Price/Sales 0.15
  • Price/Cash Flow 43.30
  • Price/Book 0.39

Options Overview Details

View History
  • Implied Volatility 157.36% (-167.03%)
  • Historical Volatility 200.10%
  • IV Percentile 90%
  • IV Rank 29.91%
  • IV High 369.49% on 12/08/25
  • IV Low 66.83% on 12/24/24
  • Expected Move (DTE 8) 0.6205 (20.82%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 14,595
  • Volume Avg (30-Day) 2,027
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 11,526
  • Open Int (30-Day) 60,937
  • Expected Range 2.3595 to 3.6005

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate 0.04
  • Number of Estimates 1
  • High Estimate 0.04
  • Low Estimate 0.04
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -63.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5700 +89.81%
on 12/09/25
4.0500 -26.42%
on 12/11/25
+0.2900 (+10.78%)
since 11/11/25
3-Month
1.5700 +89.81%
on 12/09/25
4.0500 -26.42%
on 12/11/25
+0.1500 (+5.30%)
since 09/11/25
52-Week
1.5700 +89.81%
on 12/09/25
6.0800 -50.99%
on 12/12/24
-3.0500 (-50.58%)
since 12/11/24

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised...

PETS : 2.9800 (+68.36%)
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited

DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company” or “PetMeds”), today confirmed that it...

PETS : 2.9800 (+68.36%)
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection,...

PETS : 2.9800 (+68.36%)
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa. , Nov. 28, 2025 /PRNewswire/ -- Edelson Lechtzin LLP  is investigating potential violations of the federal securities laws involving PetMed Express, Inc. (NASDAQ: PETS), resulting...

PETS : 2.9800 (+68.36%)
PetMeds Extends Existing Shareholder Rights Plan

DELRAY BEACH, Fla., Nov. 26, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced that its Board of Directors...

PETS : 2.9800 (+68.36%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS).  Such investors are advised...

PETS : 2.9800 (+68.36%)
PetMed Express, Inc. Announces Preliminary Second Quarter Results and Filing of Form 12b-25; Company Receives Expected Notice of Non-Compliance from Nasdaq

DELRAY BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today announced preliminary second quarter...

PETS : 2.9800 (+68.36%)
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair

Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 ...

PETS : 2.9800 (+68.36%)
PetMeds® Files Form 10-K for Fiscal 2025

DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange...

PETS : 2.9800 (+68.36%)
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz continues its investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS ) on behalf of investors concerning the Company’s...

PETS : 2.9800 (+68.36%)

Business Summary

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive...

See More

Key Turning Points

3rd Resistance Point 5.5400
2nd Resistance Point 4.7900
1st Resistance Point 3.8900
Last Price 2.9800
1st Support Level 2.2400
2nd Support Level 1.4900
3rd Support Level 0.5900

See More

52-Week High 6.0800
Fibonacci 61.8% 4.3600
Fibonacci 50% 3.8300
Fibonacci 38.2% 3.2900
Last Price 2.9800
52-Week Low 1.5700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar